Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet?
Stem cell-derived endothelial cells for cardiovascular disease: a therapeutic perspective
Human stem cell-derived astrocytes and their application to studying Nrf2-mediated neuroprotective pathways and therapeutics in neurodegeneration
Incidence and risk of hypertension with vandetanib in cancer patients: a systematic review and meta-analysis of clinical trials
Current and emerging antiviral treatments for hepatitis C infection
Overview of pharmacoeconomic modelling methods
The Hypertension in the Very Elderly Trial – latest data
Incident diabetes and statins: the blemish of an undisputed heavy weight champion?
ICH E14 Q & A (R1) document: perspectives on the updated recommendations on thorough QT studies
A randomized trial of the safety, pharmacokinetics and pharmacodynamics of edoxaban, an oral factor Xa inhibitor, following a switch from warfarin
Exenatide at therapeutic and supratherapeutic concentrations does not prolong the QTc interval in healthy subjects
A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects
Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose
Prediction of free imatinib concentrations based on total plasma concentrations in patients with gastrointestinal stromal tumours
Predicted metabolic drug clearance with increasing adult age
Effects of the TRPV1 antagonist ABT-102 on body temperature in healthy volunteers: pharmacokinetic/ pharmacodynamic analysis of three phase 1 trials
Effect of blueberry juice on clearance of buspirone and flurbiprofen in human volunteers
Oral bioavailability of dabigatran etexilate (Pradaxa®) after co-medication with verapamil in healthy subjects
Tramadol and hypoglycaemia: comparison with other step 2 analgesic drugs
External evaluation of population pharmacokinetic models of vancomycin in neonates: the transferability of published models to different clinical settings
Pharmacokinetic comparison of inhaled fixed combination vs . the free combination of beclomethasone and formoterol pMDIs in asthmatic children
Reasons that prevent the inclusion of Alzheimer's disease patients in clinical trials
Observational study on safety and tolerability of duloxetine in the treatment of female stress urinary incontinence in German routine practice
What can we learn from parents about enhancing participation in pharmacovigilance?
Statins and risk of treated incident diabetes in a primary care population
Psychotropic drugs and risk of motor vehicle accidents: a population-based case-control study
Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340 000 pregnancies using Norwegian population-based databases
The influence of drug use in university hospitals on the pharmaceutical consumption in their surrounding communities
Disclosure of grounds of European withdrawn and refused applications: a step forward on regulatory transparency
Epigenetic drugs for Alzheimer's disease
Epigenetic drugs for Alzheimer's disease: hopes and challenges
A case of acute liver failure due to etodolac
Stockley's Drug Interactions – Pocket companion (Editor) edited by Karen Baxter. Published by Pharmaceutical Press, London. 2012. 603 pp, price £25.99. ISBN: 9780857110251
Translation Section